ScholarIQanswers from OpenAlex

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β

PaperCitations, authors & open-access status

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β have?

ScholarIQcitation count

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β has 492 citations in the OpenAlex counts ScholarIQ stores.

When was Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β published?

ScholarIQyear

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β has 2007 year in the ScholarIQ index.

What is the open-access status of Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β?

ScholarIQoa status

Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β has bronze oa status in the ScholarIQ index.

What is the DOI of Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β?

ScholarIQdoi

The DOI for Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β is on the source record.

What is the PMID of Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β?

ScholarIQpmid

The PMID for Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β is on the source record.

What is the OpenAlex record for Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β?

ScholarIQopenalex

The OpenAlex for Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial